Signaturefd LLC Has $1.52 Million Holdings in UnitedHealth Group Inc (UNH)
Signaturefd LLC boosted its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 10.3% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,192 shares of the healthcare conglomerate’s stock after buying an additional 578 shares during the period. Signaturefd LLC’s holdings in UnitedHealth Group were worth $1,519,000 at the end of the most recent quarter.
A number of other institutional investors have also recently made changes to their positions in UNH. Welch Group LLC acquired a new stake in shares of UnitedHealth Group in the 2nd quarter valued at approximately $106,000. Blue Chip Partners Inc. acquired a new stake in shares of UnitedHealth Group in the 2nd quarter valued at approximately $107,000. Northwest Wealth Management LLC acquired a new stake in shares of UnitedHealth Group in the 2nd quarter valued at approximately $117,000. Fort L.P. acquired a new stake in shares of UnitedHealth Group in the 2nd quarter valued at approximately $119,000. Finally, Bamco Inc. NY acquired a new stake in shares of UnitedHealth Group in the 1st quarter valued at approximately $117,000. Hedge funds and other institutional investors own 85.30% of the company’s stock.
NYSE:UNH opened at $263.51 on Wednesday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.75 and a current ratio of 0.75. UnitedHealth Group Inc has a one year low of $186.00 and a one year high of $271.16. The company has a market cap of $256.66 billion, a P/E ratio of 26.17, a price-to-earnings-growth ratio of 1.59 and a beta of 0.71.
UnitedHealth Group declared that its board has initiated a stock repurchase program on Wednesday, June 6th that permits the company to buyback 100,000,000 shares. This buyback authorization permits the healthcare conglomerate to reacquire shares of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s board believes its shares are undervalued.
The company also recently declared a quarterly dividend, which was paid on Tuesday, September 18th. Shareholders of record on Friday, September 7th were issued a dividend of $0.90 per share. The ex-dividend date of this dividend was Thursday, September 6th. This represents a $3.60 annualized dividend and a yield of 1.37%. UnitedHealth Group’s payout ratio is 35.75%.
In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 177 shares of the firm’s stock in a transaction that occurred on Wednesday, July 18th. The shares were sold at an average price of $255.72, for a total transaction of $45,262.44. Following the completion of the transaction, the director now owns 29,053 shares in the company, valued at approximately $7,429,433.16. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Steven H. Nelson sold 8,142 shares of the firm’s stock in a transaction that occurred on Thursday, September 13th. The stock was sold at an average price of $265.00, for a total transaction of $2,157,630.00. Following the transaction, the chief executive officer now owns 22,496 shares of the company’s stock, valued at approximately $5,961,440. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 94,745 shares of company stock valued at $24,995,290. Company insiders own 0.87% of the company’s stock.
A number of equities research analysts have recently weighed in on UNH shares. Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, May 31st. BMO Capital Markets raised their price target on shares of UnitedHealth Group from $275.00 to $285.00 and gave the company a “buy” rating in a research note on Thursday, June 7th. SunTrust Banks started coverage on shares of UnitedHealth Group in a research note on Monday, June 11th. They issued a “buy” rating and a $300.00 price target on the stock. Cantor Fitzgerald reiterated a “buy” rating and set a $300.00 target price on shares of UnitedHealth Group in a research report on Thursday, July 5th. Finally, Goldman Sachs Group reiterated a “buy” rating and set a $277.00 target price on shares of UnitedHealth Group in a research report on Tuesday, July 17th. Two research analysts have rated the stock with a hold rating, twenty-one have issued a buy rating and one has issued a strong buy rating to the stock. UnitedHealth Group currently has a consensus rating of “Buy” and a consensus price target of $275.87.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Read More: Do stock splits help investors?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.